文献速递复苏、休克与脓毒症重症综合管理与镇静镇痛

医院医学安全脓毒症倡议死亡模型的开发与验证

Development and Validation of the Hospital Medicine Safety Sepsis Initiative Mortality Model.
PubMed 文献 · Chest · 2024-07-02
一句话结论HMS-Sepsis死亡模型在社区起病脓毒症住院患者中区分度强(验证队列C统计量0.81)、校准良好,可使33.9%的医院风险调整后 performance 分类不同于未调整死亡率。

本研究基于密歇根医院医学安全脓毒症倡议(HMS-Sepsis)登记数据,纳入2022年4月至2023年9月66家医院17,514例社区起病脓毒症住院患者,按70%推导、30%验证拆分,建立包含13个生理变量、2个生理交互项和16个人口学及慢性健康变量的30天死亡风险调整模型。总队列30天死亡率为19.4%;模型C统计量推导队列0.82、验证队列0.81,所有亚组≥0.78;总体校准误差0.0%,十分位风险平均校准误差1.5%。标准化死亡比使33.9%的医院绩效评估与观察死亡率不同。作者认为该模型可能有助于公平的医院基准比较、时间变化评估和观察性因果推断分析。

要点

  • HMS-Sepsis模型纳入13个生理变量、2个生理交互项和16个人口学及慢性健康变量,用于社区起病脓毒症住院患者30天死亡风险调整。
  • 验证队列C统计量0.81,推导队列0.82,所有评估亚组C统计量≥0.78;总体校准误差0.0%,十分位风险平均校准误差1.5%。
  • 总队列30天死亡率为19.4%;标准化死亡比使33.9%的医院绩效评估与观察死亡率不同。
  • 最显著的预测变量包括年龄、转移性实体瘤、体温、意识状态改变和血小板计数。

适用人群与场景

  • HMS-Sepsis登记中2022年4月至2023年9月的社区起病脓毒症住院患者,来自66家医院,共17,514例住院。

研究设计与关键结果

  • 研究类型:回顾性队列,基于HMS-Sepsis登记,按70%推导队列(12,260例住院)和30%验证队列(5,254例住院)拆分。
  • 总队列30天死亡率为19.4%。
  • 最终模型包含13个生理变量、2个生理交互项和16个人口学及慢性健康变量。
  • 最显著的变量为年龄、转移性实体瘤、体温、意识状态改变和血小板计数。
  • 模型C统计量:推导队列0.82,验证队列0.81,所有评估亚组≥0.78。
  • 总体校准误差0.0%,十分位风险平均校准误差1.5%。
  • 标准化死亡比使33.9%的医院绩效评估与观察死亡率不同。

证据类型、等级与局限

  • 证据类型:回顾性队列研究(模型开发与验证)。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,基于其良好性能,HMS-Sepsis死亡模型可能有助于公平的医院基准比较、时间变化评估和观察性因果推断分析。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: When comparing outcomes after sepsis, it is essential to account for patient case mix to make fair comparisons. We developed a model to assess risk-adjusted 30-day mortality in the Michigan Hospital Medicine Safety sepsis initiative (HMS-Sepsis).

RESEARCH QUESTION: Can HMS-Sepsis registry data adequately predict risk of 30-day mortality? Do performance assessments using adjusted vs unadjusted data differ?

STUDY DESIGN AND METHODS: Retrospective cohort of community-onset sepsis hospitalizations in the HMS-Sepsis registry (April 2022-September 2023), with split derivation (70%) and validation (30%) cohorts. We fit a risk-adjustment model (HMS-Sepsis mortality model) incorporating acute physiologic, demographic, and baseline health data and assessed model performance using concordance (C) statistics, Brier scores, and comparisons of predicted vs observed mortality by deciles of risk. We compared hospital performance (first quintile, middle quintiles, fifth quintile) using observed vs adjusted mortality to understand the extent to which risk adjustment impacted hospital performance assessment.

RESULTS: Among 17,514 hospitalizations from 66 hospitals during the study period, 12,260 hospitalizations (70%) were used for model derivation and 5,254 hospitalizations (30%) were used for model validation. Thirty-day mortality for the total cohort was 19.4%. The final model included 13 physiologic variables, two physiologic interactions, and 16 demographic and chronic health variables. The most significant variables were age, metastatic solid tumor, temperature, altered mental status, and platelet count. The model C statistic was 0.82 for the derivation cohort, 0.81 for the validation cohort, and ≥ 0.78 for all subgroups assessed. Overall calibration error was 0.0%, and mean calibration error across deciles of risk was 1.5%. Standardized mortality ratios yielded different assessments than observed mortality for 33.9% of hospitals.

INTERPRETATION: The HMS-Sepsis mortality model showed strong discrimination and adequate calibration and reclassified one-third of hospitals to a different performance category from unadjusted mortality. Based on its strong performance, the HMS-Sepsis mortality model may aid in fair hospital benchmarking, assessment of temporal changes, and observational causal inference analysis.

来源:Chest,查看原文。版权归原作者所有。

参考来源

  1. Prescott HC, Heath M, Munroe ES, et al. Development and Validation of the Hospital Medicine Safety Sepsis Initiative Mortality Model. Chest. 2024. PMID: 38964673. doi:10.1016/j.chest.2024.06.3769

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。